{"id":"NCT01973452","sponsor":"Memorial Sloan Kettering Cancer Center","briefTitle":"Placebo Controlled Clinical Trial of the Postoperative Opioid Sparing Effects of Intraoperative Dexmedetomidine Infusion for Thoracic Surgery","officialTitle":"A Double-Masked Placebo Controlled Clinical Trial of the Postoperative Opioid Sparing Effects of Intraoperative Dexmedetomidine Infusion for Thoracic Surgery","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10","primaryCompletion":"2022-12-22","completion":"2022-12-22","firstPosted":"2013-10-31","resultsPosted":"2024-02-20","lastUpdate":"2024-02-20"},"enrollment":333,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pain"],"interventions":[{"type":"DRUG","name":"Dexmedetomidine","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Dexmedetomidine","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to see if the drug, Dexmedetomidine (also known as Precedex), can reduce pain for patients having Thoracic Surgery and therefore reduce the amount of opioid drug needed after surgery. It is a drug that is already approved by the FDA (Food \\& Drug Administration) for use as a sedative in hospitals and is currently used in the investigators Intensive Care Unit for this purpose. The investigators want to investigate if it also has pain relieving properties.","primaryOutcome":{"measure":"Total Opioid Administered","timeFrame":"up to 4 hours","effectByArm":[{"arm":"Dexmedetomidine","deltaMin":4,"sd":null},{"arm":"Placebo","deltaMin":6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"21 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":11},"locations":{"siteCount":4,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["http://www.mskcc.org/"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":148},"commonTop":[]}}